TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 35.80
0.00 (0.00%)
Sep 15, 2026, 1:27 PM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 947.21 million as of September 15, 2026. Its market cap has decreased by -13.73% in one year.
Market Cap
947.21M
Enterprise Value
115.94M
Revenue
251.39M
Ranking
n/a
PE Ratio
18.86
Stock Price
35.80
ChartMarket Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 947.21M, a decrease of -55.64%. That is a compound annual growth rate of -16.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 768.22M | -18.21% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.09B |
| Bio Preventive Medicine | 1.09B |
| LabTurbo Biotech | 1.08B |
| Level Biotechnology | 1.03B |
| Holy Stone Healthcare | 963.43M |
| GeneReach Biotechnology | 918.26M |
| NatureWise Biotech & Medicals | 867.37M |
| Meribank Biotech | 858.99M |